BACKGROUND AND PURPOSE: We aim to investigate whether lower admission serum calcium levels are associated with hemorrhagic transformation (HT) after intravenous thrombolysis (IVT). METHODS: A total of 362 patients treated with IVT was divided into 4 quartiles based on admission serum calcium levels (Q1[<2.16], Q2[2.16, 2.23], Q3[2.24, 2.31], and Q4[>2.31] mmol/L). HT was classified as hemorrhagic infarction and parenchymal hemorrhage. Logistic regression was applied to assess the association between serum calcium levels and the incidence of HT. RESULTS: Compared with Q4, HT was more common in Q1 (odds ratio, 2.580; 95% CI, [1.258-5.292]; P=0.010), Q2 (odds ratio, 2.382; 95% CI, [1.163-4.877]; P=0.018), and Q3 (odds ratio, 2.293; 95% CI, [1.133-4.637]; P=0.021). Hemorrhagic infarction was more common in Q1 (P=0.037), and Q2 (P=0.018), compared with Q4, and parenchymal hemorrhage was more common in Q1 (P=0.029) than Q4. CONCLUSIONS: Lower admission serum calcium level is independently associated with HT after IVT, and this hypothesis needs larger confirmatory trials.
BACKGROUND AND PURPOSE: We aim to investigate whether lower admission serum calcium levels are associated with hemorrhagic transformation (HT) after intravenous thrombolysis (IVT). METHODS: A total of 362 patients treated with IVT was divided into 4 quartiles based on admission serum calcium levels (Q1[<2.16], Q2[2.16, 2.23], Q3[2.24, 2.31], and Q4[>2.31] mmol/L). HT was classified as hemorrhagic infarction and parenchymal hemorrhage. Logistic regression was applied to assess the association between serum calcium levels and the incidence of HT. RESULTS: Compared with Q4, HT was more common in Q1 (odds ratio, 2.580; 95% CI, [1.258-5.292]; P=0.010), Q2 (odds ratio, 2.382; 95% CI, [1.163-4.877]; P=0.018), and Q3 (odds ratio, 2.293; 95% CI, [1.133-4.637]; P=0.021). Hemorrhagic infarction was more common in Q1 (P=0.037), and Q2 (P=0.018), compared with Q4, and parenchymal hemorrhage was more common in Q1 (P=0.029) than Q4. CONCLUSIONS: Lower admission serum calcium level is independently associated with HT after IVT, and this hypothesis needs larger confirmatory trials.
Authors: J H Park; Y Ko; W-J Kim; M S Jang; M H Yang; M-K Han; C-W Oh; S H Park; Jisung Lee; Juneyoung Lee; H-J Bae; P B Gorelick Journal: Neurology Date: 2012-01-25 Impact factor: 9.910
Authors: Bruce C V Campbell; Søren Christensen; Christopher R Levi; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis; Mark W Parsons Journal: Stroke Date: 2011-10-06 Impact factor: 7.914
Authors: Bruce Ovbiagele; Sidney Starkman; Philip Teal; Patrick Lyden; Markku Kaste; Stephen M Davis; Werner Hacke; Monika Fierus; Jeffrey L Saver Journal: Stroke Date: 2008-06-26 Impact factor: 7.914
Authors: Imanuel Dzialowski; J H Warwick Pexman; Philip A Barber; Andrew M Demchuk; Alastair M Buchan; Michael D Hill Journal: Stroke Date: 2006-11-22 Impact factor: 7.914
Authors: Sarah R Martha; Lisa A Collier; Stephanie M Davis; Sarah J Goodwin; David Powell; Doug Lukins; Justin F Fraser; Keith R Pennypacker Journal: J Neurosci Res Date: 2019-04-03 Impact factor: 4.164
Authors: Sarah R Martha; Lisa A Collier; Stephanie M Davis; Hilary A Seifert; Christopher C Leonardo; Craig T Ajmo; Elspeth A Foran; Justin F Fraser; Keith R Pennypacker Journal: J Stroke Cerebrovasc Dis Date: 2018-07-29 Impact factor: 2.136
Authors: Andrea Morotti; Andreas Charidimou; Chia-Ling Phuah; Michael J Jessel; Kristin Schwab; Alison M Ayres; Javier M Romero; Anand Viswanathan; M Edip Gurol; Steven M Greenberg; Christopher D Anderson; Jonathan Rosand; Joshua N Goldstein Journal: JAMA Neurol Date: 2016-11-01 Impact factor: 18.302
Authors: Junfeng Liu; Deren Wang; Yao Xiong; Bian Liu; Chenchen Wei; Zhenxing Ma; Bo Wu; Ruozhen Yuan; Hehan Tang; Ming Liu Journal: Medicine (Baltimore) Date: 2016-06 Impact factor: 1.889